151 related articles for article (PubMed ID: 26275806)
41. A conservative amino acid change alters the function of BosR, the redox regulator of Borrelia burgdorferi.
Seshu J; Boylan JA; Hyde JA; Swingle KL; Gherardini FC; Skare JT
Mol Microbiol; 2004 Dec; 54(5):1352-63. PubMed ID: 15554974
[TBL] [Abstract][Full Text] [Related]
42. Structural characterization of CspZ, a complement regulator factor H and FHL-1 binding protein from Borrelia burgdorferi.
Brangulis K; Petrovskis I; Kazaks A; Bogans J; Otikovs M; Jaudzems K; Ranka R; Tars K
FEBS J; 2014 Jun; 281(11):2613-22. PubMed ID: 24702793
[TBL] [Abstract][Full Text] [Related]
43. Profiling the humoral immune response to Borrelia burgdorferi infection with protein microarrays.
Xu Y; Bruno JF; Luft BJ
Microb Pathog; 2008; 45(5-6):403-7. PubMed ID: 18976702
[TBL] [Abstract][Full Text] [Related]
44. Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection.
Weening EH; Parveen N; Trzeciakowski JP; Leong JM; Höök M; Skare JT
Infect Immun; 2008 Dec; 76(12):5694-705. PubMed ID: 18809667
[TBL] [Abstract][Full Text] [Related]
45. RNA-Seq-based analysis of changes in Borrelia burgdorferi gene expression linked to pathogenicity.
Wu Q; Guan G; Liu Z; Li Y; Luo J; Yin H
Parasit Vectors; 2015 Mar; 8():155. PubMed ID: 25886272
[TBL] [Abstract][Full Text] [Related]
46. Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host.
Norman MU; Moriarty TJ; Dresser AR; Millen B; Kubes P; Chaconas G
PLoS Pathog; 2008 Oct; 4(10):e1000169. PubMed ID: 18833295
[TBL] [Abstract][Full Text] [Related]
47. Recombinant or peptide antigens in the serology of Lyme arthritis in children.
Heikkilä T; Huppertz HI; Seppälä I; Sillanpää H; Saxen H; Lahdenne P
J Infect Dis; 2003 Jun; 187(12):1888-94. PubMed ID: 12792865
[TBL] [Abstract][Full Text] [Related]
48. Adherence of Borrelia burgdorferi to the proteoglycan decorin.
Guo BP; Norris SJ; Rosenberg LC; Höök M
Infect Immun; 1995 Sep; 63(9):3467-72. PubMed ID: 7642279
[TBL] [Abstract][Full Text] [Related]
49. Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi.
Seshu J; Esteve-Gassent MD; Labandeira-Rey M; Kim JH; Trzeciakowski JP; Höök M; Skare JT
Mol Microbiol; 2006 Mar; 59(5):1591-601. PubMed ID: 16468997
[TBL] [Abstract][Full Text] [Related]
50. Strain variation in glycosaminoglycan recognition influences cell-type-specific binding by lyme disease spirochetes.
Parveen N; Robbins D; Leong JM
Infect Immun; 1999 Apr; 67(4):1743-9. PubMed ID: 10085013
[TBL] [Abstract][Full Text] [Related]
51. RpoS is not central to the general stress response in Borrelia burgdorferi but does control expression of one or more essential virulence determinants.
Caimano MJ; Eggers CH; Hazlett KR; Radolf JD
Infect Immun; 2004 Nov; 72(11):6433-45. PubMed ID: 15501774
[TBL] [Abstract][Full Text] [Related]
52. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses.
Liang FT; Yan J; Mbow ML; Sviat SL; Gilmore RD; Mamula M; Fikrig E
Infect Immun; 2004 Oct; 72(10):5759-67. PubMed ID: 15385475
[TBL] [Abstract][Full Text] [Related]
53. Delineation of species-specific binding properties of the CspZ protein (BBH06) of Lyme disease spirochetes: evidence for new contributions to the pathogenesis of Borrelia spp.
Rogers EA; Marconi RT
Infect Immun; 2007 Nov; 75(11):5272-81. PubMed ID: 17846117
[TBL] [Abstract][Full Text] [Related]
54. Vascular binding of a pathogen under shear force through mechanistically distinct sequential interactions with host macromolecules.
Moriarty TJ; Shi M; Lin YP; Ebady R; Zhou H; Odisho T; Hardy PO; Salman-Dilgimen A; Wu J; Weening EH; Skare JT; Kubes P; Leong J; Chaconas G
Mol Microbiol; 2012 Dec; 86(5):1116-31. PubMed ID: 23095033
[TBL] [Abstract][Full Text] [Related]
55. Age-dependent alterations of decorin glycosaminoglycans in human skin.
Li Y; Liu Y; Xia W; Lei D; Voorhees JJ; Fisher GJ
Sci Rep; 2013; 3():2422. PubMed ID: 23939413
[TBL] [Abstract][Full Text] [Related]
56. [New aspects of the pathogenesis of lyme disease].
Zajkowska JM; Hermanowska-Szpakowicz T
Przegl Epidemiol; 2002; 56 Suppl 1():57-67. PubMed ID: 12194230
[TBL] [Abstract][Full Text] [Related]
57. Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix.
Cabello FC; Godfrey HP; Newman SA
Trends Microbiol; 2007 Aug; 15(8):350-4. PubMed ID: 17600717
[TBL] [Abstract][Full Text] [Related]
58. Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1.
Hartmann K; Corvey C; Skerka C; Kirschfink M; Karas M; Brade V; Miller JC; Stevenson B; Wallich R; Zipfel PF; Kraiczy P
Mol Microbiol; 2006 Sep; 61(5):1220-36. PubMed ID: 16925556
[TBL] [Abstract][Full Text] [Related]
59. Cyclic-di-GMP binding induces structural rearrangements in the PlzA and PlzC proteins of the Lyme disease and relapsing fever spirochetes: a possible switch mechanism for c-di-GMP-mediated effector functions.
Mallory KL; Miller DP; Oliver LD; Freedman JC; Kostick-Dunn JL; Carlyon JA; Marion JD; Bell JK; Marconi RT
Pathog Dis; 2016 Nov; 74(8):. PubMed ID: 27852620
[TBL] [Abstract][Full Text] [Related]
60. Insight into the Dual Functions of Bacterial Enhancer-Binding Protein Rrp2 of Borrelia burgdorferi.
Yin Y; Yang Y; Xiang X; Wang Q; Yang ZN; Blevins J; Lou Y; Yang XF
J Bacteriol; 2016 May; 198(10):1543-52. PubMed ID: 26977110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
